Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Turning Stem Cells Bad: Generation of Clinically Relevant Models of Human Acute Myeloid Leukemia through Gene Delivery- or Genome Editing-Based Approaches.

Mesuraca M, Amodio N, Chiarella E, Scicchitano S, Aloisio A, Codispoti B, Lucchino V, Montalcini Y, Bond HM, Morrone G.

Molecules. 2018 Aug 17;23(8). pii: E2060. doi: 10.3390/molecules23082060. Review.

2.

ZNF521 Has an Inhibitory Effect on the Adipogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells.

Chiarella E, Aloisio A, Codispoti B, Nappo G, Scicchitano S, Lucchino V, Montalcini Y, Camarotti A, Galasso O, Greco M, Gasparini G, Mesuraca M, Bond HM, Morrone G.

Stem Cell Rev. 2018 Jun 25. doi: 10.1007/s12015-018-9830-0. [Epub ahead of print]

PMID:
29938352
3.

ZNF423: A New Player in Estrogen Receptor-Positive Breast Cancer.

Bond HM, Scicchitano S, Chiarella E, Amodio N, Lucchino V, Aloisio A, Montalcini Y, Mesuraca M, Morrone G.

Front Endocrinol (Lausanne). 2018 May 18;9:255. doi: 10.3389/fendo.2018.00255. eCollection 2018. Review.

4.

Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells.

Codispoti B, Rinaldo N, Chiarella E, Lupia M, Spoleti CB, Marafioti MG, Aloisio A, Scicchitano S, Giordano M, Nappo G, Lucchino V, Moore MAS, Zhou P, Mesuraca M, Bond HM, Morrone G.

Oncotarget. 2017 Jul 4;8(27):43782-43798. doi: 10.18632/oncotarget.15156.

5.

ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.

Mesuraca M, Chiarella E, Scicchitano S, Codispoti B, Giordano M, Nappo G, Bond HM, Morrone G.

Biomed Res Int. 2015;2015:165238. doi: 10.1155/2015/165238. Epub 2015 Dec 16. Review.

6.

Validation of a novel shotgun proteomic workflow for the discovery of protein-protein interactions: focus on ZNF521.

Bernaudo F, Monteleone F, Mesuraca M, Krishnan S, Chiarella E, Scicchitano S, Cuda G, Morrone G, Bond HM, Gaspari M.

J Proteome Res. 2015 Apr 3;14(4):1888-99. doi: 10.1021/pr501288h. Epub 2015 Mar 24.

PMID:
25774781
7.

Mechanical stress downregulates MHC class I expression on human cancer cell membrane.

La Rocca R, Tallerico R, Talib Hassan A, Das G, Lakshmikanth T, Matteucci M, Liberale C, Mesuraca M, Scumaci D, Gentile F, Cojoc G, Perozziello G, Ammendolia A, Gallo A, Kärre K, Cuda G, Candeloro P, Di Fabrizio E, Carbone E.

PLoS One. 2014 Dec 26;9(12):e111758. doi: 10.1371/journal.pone.0111758. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0118519. Tadepally, Lakshmikanth [corrected to Lakshmikanth, Tadepally].

8.

UMG Lenti: novel lentiviral vectors for efficient transgene- and reporter gene expression in human early hematopoietic progenitors.

Chiarella E, Carrà G, Scicchitano S, Codispoti B, Mega T, Lupia M, Pelaggi D, Marafioti MG, Aloisio A, Giordano M, Nappo G, Spoleti CB, Grillone T, Giovannone ED, Spina R, Bernaudo F, Moore MA, Bond HM, Mesuraca M, Morrone G.

PLoS One. 2014 Dec 12;9(12):e114795. doi: 10.1371/journal.pone.0114795. eCollection 2014.

9.

Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide.

Gallelli L, Falcone D, Scaramuzzino M, Pelaia G, D'Agostino B, Mesuraca M, Terracciano R, Spaziano G, Maselli R, Navarra M, Savino R.

BMC Pharmacol Toxicol. 2014 Nov 29;15:67. doi: 10.1186/2050-6511-15-67.

10.

Expression profiling and functional implications of a set of zinc finger proteins, ZNF423, ZNF470, ZNF521, and ZNF780B, in primary osteoarthritic articular chondrocytes.

Mesuraca M, Galasso O, Guido L, Chiarella E, Scicchitano S, Vatrinet R, Morrone G, Bond HM, Gasparini G.

Mediators Inflamm. 2014;2014:318793. doi: 10.1155/2014/318793. Epub 2014 May 27.

11.

Targeting leukemia stem cells: in vitro veritas?

Bond HM, Mesuraca M, Morrone G.

Oncotarget. 2014 Feb 15;5(3):575-6. No abstract available.

12.

IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation.

Massimino M, Consoli ML, Mesuraca M, Stagno F, Tirrò E, Stella S, Pennisi MS, Romano C, Buffa P, Bond HM, Morrone G, Sciacca L, Di Raimondo F, Manzella L, Vigneri P.

Carcinogenesis. 2014 May;35(5):1132-43. doi: 10.1093/carcin/bgu013. Epub 2014 Jan 20.

PMID:
24445143
13.

Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells.

Spina R, Filocamo G, Iaccino E, Scicchitano S, Lupia M, Chiarella E, Mega T, Bernaudo F, Pelaggi D, Mesuraca M, Pazzaglia S, Semenkow S, Bar EE, Kool M, Pfister S, Bond HM, Eberhart CG, Steinkühler C, Morrone G.

Oncotarget. 2013 Aug;4(8):1280-92.

14.

Zinc finger protein 521 antagonizes early B-cell factor 1 and modulates the B-lymphoid differentiation of primary hematopoietic progenitors.

Mega T, Lupia M, Amodio N, Horton SJ, Mesuraca M, Pelaggi D, Agosti V, Grieco M, Chiarella E, Spina R, Moore MA, Schuringa JJ, Bond HM, Morrone G.

Cell Cycle. 2011 Jul 1;10(13):2129-39. Epub 2011 Jul 1.

PMID:
21593590
15.

Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome gene.

Leuci V, Gammaitoni L, Capellero S, Sangiolo D, Mesuraca M, Bond HM, Migliardi G, Cammarata C, Aglietta M, Morrone G, Piacibello W.

Stem Cells. 2009 Nov;27(11):2815-23. doi: 10.1002/stem.224.

16.

Early hematopoietic zinc finger protein prevents tumor cell recognition by natural killer cells.

La Rocca R, Fulciniti M, Lakshmikanth T, Mesuraca M, Ali TH, Mazzei V, Amodio N, Catalano L, Rotoli B, Ouerfelli O, Grieco M, Gulletta E, Bond HM, Morrone G, Ferrone S, Carbone E.

J Immunol. 2009 Apr 15;182(8):4529-37. doi: 10.4049/jimmunol.0802109.

17.

Early hematopoietic zinc finger protein-zinc finger protein 521: a candidate regulator of diverse immature cells.

Bond HM, Mesuraca M, Amodio N, Mega T, Agosti V, Fanello D, Pelaggi D, Bullinger L, Grieco M, Moore MA, Venuta S, Morrone G.

Int J Biochem Cell Biol. 2008;40(5):848-54. Epub 2007 Apr 21. Review.

PMID:
17543573
18.

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, Groh V, Spies T, Pollio G, Cosman D, Catalano L, Tassone P, Rotoli B, Venuta S.

Blood. 2005 Jan 1;105(1):251-8. Epub 2004 Aug 24.

19.

Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells.

Bond HM, Mesuraca M, Carbone E, Bonelli P, Agosti V, Amodio N, De Rosa G, Di Nicola M, Gianni AM, Moore MA, Hata A, Grieco M, Morrone G, Venuta S.

Blood. 2004 Mar 15;103(6):2062-70. Epub 2003 Nov 20.

Supplemental Content

Loading ...
Support Center